Article

At AGBT 2026, Volta Labs launched significant advancements in genomic sequencing, including the integration of Roche's AXELIOS 1 into its Callisto platform and the introduction of a PCR-free WGS Complete Kit with Watchmaker Genomics. These innovations support automated, high-quality library preparation and aim to simplify workflows for customers using next-generation sequencers.

Presentations, including one by Hartwig Medical Foundation on ctDNA, highlighted Callisto's operational advantages, showcasing its role in advancing clinical-grade sequencing. Volta Labs is also pursuing an apps-based model for genomics, promoting streamlined workflows and automation across various sequencing applications.